Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 30184
Estimating the Absorbed Dose to THYROID during Chest wall Radiotherapy

Authors: Seid Ali Asghar Terohid, Vahid Fayaz

Abstract:

Thyroid cancer-s overall contribution to the worldwide cancer burden is relatively small, but incidence rates have increased over the last three decades throughout the world. This trend has been hypothesised to reflect a combination of technological advances enabling increased detection, but also changes in environmental factors, including population exposure to ionising radiation from fallout, diagnostic tests and treatment for benign and malignant conditions. The Thyroid dose received apparently shielded by cerrobend blocks was about 8cGy in 100cGy Expose

Keywords: Absorbed Dose, Thyroid, Radiotherapy

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1331215

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 1314

References:


[1] National Council on Radiation Protection and Measurements. Scientific Committee 6e2 on Radiation Exposure of the U.S. Population. Ionizing radiation exposure of the population of the united states: recommendations of the national council on radiation protection and measurements. Bethesda, MD: National Council on Radiation Protection and Measurements;2009.
[2] Bhatti P, Veiga LH, Ronckers CX, et al. Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res 2010;174:751e752.
[3] Ng AK, Kenney LB, Gilbert ES, Travis LB. Secondary malignancies across the age spectrum. Semin Radiat Oncol 2010;20 (1):67e78.
[4] Bhatia S, Yasui Y, Robison LL, et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin-s disease: report from the Late Effects Study Group. J Clin Oncol 2003;21(23):4386e4394.
[5] Sinnott B, Ron E, Schneider AB. Exposing the thyroid to radiation: a review of its current extent, risks, and implications. Endocr Rev 2010;31(5):756e773.
[6] United Nations. Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation: United Nations Scientific Committee on the Effects of Atomic Radiation: Volume I: Sources - Report to the General Assembly Scientific Annexes A and B 2008. New York: United Nations.
[7] Ron E. Cancer risks from medical radiation. Health Phys 2003;85(1):47e59.
[8] S.J. Schonfeld, C. Lee, A. Berrington de Gonz_alez"Overview Medical Exposure to Radiation and Thyroid Cancer"Clinical Oncology 23 (2011) 244e250
[9] Oliver Gimm , Mini-review "Thyroid cancer" Cancer Letters 163 (2001) 143┬▒156
[10] B.M. Wenig, C.S. Heffess, C.F. Adair, Atlas of endocrine pathology, W.B. Saunders Company, Philadelphia, PA, 1997.
[11] Cannon CR. Hypothyroidism in head and neck cancer patients: experimental and clinical observations. Laryngoscope 1994;104:1-21.
[12] Einhorn J, Wilkholm MG. Hypothyroidism after external irradiation of the thyroid region. Radiology 1967;88: 326-8.
[13] Felix H, Dupre N, Drap_eM, Court L. Incidence _a long terme d-une radiotherapie pour cancer du larynx, sur l-aparition d-un myxoedeme. Lyon Med 1961;93:1043-50.
[14] Markson JL, Flatman GE. Myxedema after deep X-ray therapy to the neck. South Med J 1965;1:1228-30.
[15] Hall, Eric J.; Giaccia, Amato J" Radiobiology for the Radiologist, 6th Edition" Copyright ┬®2006 Lippincott Williams & Wilkins
[16] Ron E, Lubin JH, Shore RE, et al.: cancer after exposure to external radiation: A pooled analysis of seven studies. Radiat Res 141:259-277, 1995
[17] Rotblat J, Lindop P: Long-term effects of a single whole-body exposure of mice to ionizing radiations: II. Causes of death. Proc R Soc Lond B Biol Sci 154:350-368, 1961
[18] Saenger EL, Thoma BE, Tompkins EA: Leukemia after treatment of hyperthyroidism. JAMA 205:855-862, 1968
[19] Sankila R, Garwicz S, Olsen JH, et al.: Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: A population-based cohort study in the five Nordic countries. J Clin Oncol 14:1442-1446, 1996
[20] Shore RE, Hildreth N, Woodard E, Dvoretsky P, Hempelmann L, Pasternack B: Breast cancer among women given x-ray therapy for acute postpartum mastitis. J Natl Cancer Inst 77:689-696, 1986
[21] Shore RE, Woodard E, Hildreth N, Dvoretsky P, Hempelmann L, Pasternack B: Thyroid tumors following thymus irradiation. J Natl Cancer Inst 74:1177-1184, 1985
[22] Stewart A, Kneale GW: Changes in the cancer risk associated with obstetric radiography. Lancet 1:104-107, 1968
[23] Stewart A, Webb J, Hewitt D: A survey of childhood malignancies. Br Med J 1:1495-1508, 1958
[24] Busuoli G. General characteristics of TL materials. In: Oberhofer M, Scharmann A, editors. Applied thermoluminescence dosimetry: lectures of a course held at the Joint Research Centre, Ispra, 12-16 November 1979, 87. Bristol: Adam Hilger Ltd; 1981.
[fig. 5.4(c)].